Chronic use of renin¿angiotensin¿aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis Álvaro Aparisi; Pablo Catalá; Ignacio J. Amat-Santos; Marta Marcos-Mangas; Diego López-Otero; Carlos Veras; Javier López-Pais; Gonzalo Cabezón-Villalba; Carla Eugenia Cacho Antonio; Jordi Candela; Pablo Antúnez-Muiños; José Francisco Gil; Teba González Ferrero; Gino Rojas; Marta Pérez-Poza; Aitor Uribarri; Oscar Otero-García; Pablo Elpidio García-Granja; Víctor Jiménez Ramos; Ana Revilla; Carlos Dueñas; Itzíar Gómez; José Ramón González-Juanatey; J. Alberto San Román;

Personal and vaccination history as factors associated with SARS-CoV-2 infection María Fernández-Prada; Paula García-González; Alejandro García-Morán; Inés Ruiz-Álvarez; Covadonga Ramas-Diez; Carmen Calvo-Rodríguez;

Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine Francisco Tejada Cifuentes; Ángeles Lloret Callejo; María José Tirado Peláez; Olga Rubio Pulido; Marta Ruiz-Morote Aragón; Rocío Fernández Urrusuno; María Isabel Muñoz Carreras; María Isabel Méndez Esteban; Victoria Maestre Sánchez; Antonio García Bonilla; José Manuel Paredero Dominguez; Virginia Arroyo Pineda; Esther Marco Tejón; Gregorio Romero Candel; Ana Isabel Fernández Marchante; José Marco del Rio; Teresa Ortiz Martín; Piedad López Sánchez;